Insider Selling: Hinge Health (NYSE:HNGE) President Sells $683,550.00 in Stock

Hinge Health Inc. (NYSE:HNGEGet Free Report) President James Pursley sold 15,000 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $45.57, for a total transaction of $683,550.00. Following the sale, the president owned 789,902 shares in the company, valued at $35,995,834.14. This trade represents a 1.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Hinge Health Stock Up 3.8%

Hinge Health stock opened at $50.12 on Thursday. The firm has a 50 day moving average of $49.13. Hinge Health Inc. has a twelve month low of $33.42 and a twelve month high of $62.18.

Hinge Health (NYSE:HNGEGet Free Report) last posted its quarterly earnings data on Tuesday, November 4th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.18. The company had revenue of $154.21 million during the quarter, compared to the consensus estimate of $142.44 million. The firm’s quarterly revenue was up 53.3% on a year-over-year basis. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health announced that its Board of Directors has approved a share repurchase plan on Wednesday, November 12th that permits the company to repurchase $250.00 million in outstanding shares. This repurchase authorization permits the company to repurchase up to 7.2% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board of directors believes its stock is undervalued.

Hedge Funds Weigh In On Hinge Health

Several hedge funds and other institutional investors have recently made changes to their positions in the company. BIT Capital GmbH lifted its stake in Hinge Health by 144.6% in the third quarter. BIT Capital GmbH now owns 1,849,524 shares of the company’s stock valued at $90,775,000 after acquiring an additional 1,093,320 shares during the last quarter. Bamco Inc. NY bought a new position in Hinge Health during the second quarter worth about $48,943,000. Braidwell LP bought a new position in Hinge Health during the third quarter worth about $44,686,000. JPMorgan Chase & Co. acquired a new position in Hinge Health during the second quarter worth approximately $43,840,000. Finally, Franklin Resources Inc. acquired a new stake in shares of Hinge Health in the second quarter valued at approximately $28,462,000.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on HNGE. Robert W. Baird assumed coverage on Hinge Health in a report on Friday, September 5th. They set a “neutral” rating and a $56.00 price objective for the company. Bank of America lifted their price objective on shares of Hinge Health from $42.00 to $64.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Needham & Company LLC increased their target price on shares of Hinge Health from $47.00 to $59.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Stifel Nicolaus lifted their price target on shares of Hinge Health from $63.00 to $66.00 and gave the company a “buy” rating in a research note on Thursday, September 11th. Finally, JMP Securities boosted their price target on shares of Hinge Health from $58.00 to $65.00 and gave the stock a “market outperform” rating in a research report on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Hinge Health has a consensus rating of “Moderate Buy” and a consensus target price of $59.93.

View Our Latest Analysis on HNGE

About Hinge Health

(Get Free Report)

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

Read More

Receive News & Ratings for Hinge Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hinge Health and related companies with MarketBeat.com's FREE daily email newsletter.